Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients

Medical Oncology

Volumn 30, Issue 2, 2013, Pages

  Şahin, Mustafa ^a   Uçan, Bekir ^b   Giniş, Zeynep ^b   Topaloǧlu, Oya ^b   Güngüneş, Aşkin ^b   Bozkurt, Nujen Çolak ^b   Arslan, Müyesser Sayki ^b   Ünsal, Ilknur Öztürk ^b   Akkaymak, Esra Tutal ^b   Demirci, Taner ^b   Karaköse, Melia ^b   Çalişkan, Mustafa ^b   Çakal, Erman ^b   Özbek, Mustafa ^b   Delibaşi, Tuncay ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b Diskapi Training Research Hospital   (Turkey)

Author keywords

Beta cell function; Folic acid; Insulin resistance; Thyroglobulin; Thyroid cancer; Vitamin B12; Vitamin D3

Indexed keywords

COLECALCIFEROL; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN; CYANOCOBALAMIN; FOLIC ACID; THYROGLOBULIN;

ADULT; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THYROID CARCINOMA; TUMOR INVASION; TUMOR VOLUME; VITAMIN D DEFICIENCY; BLOOD; CARCINOMA; CASE CONTROL STUDY; HOMEOSTASIS; MIDDLE AGED; THYROID TUMOR;

ADULT; CARCINOMA; CASE-CONTROL STUDIES; CHOLECALCIFEROL; FEMALE; FOLIC ACID; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; ROC CURVE; THYROGLOBULIN; THYROID NEOPLASMS; VITAMIN B 12;

EID: 84876862385     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0589-5     Document Type: Article

References (26)

1. Cooper DS, Doherty GM, Haugen BR, et al. Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-214.
2. Sahin M, Mciver B. Thyroid carcinoma. In: Hospital Physician, Endocrinology board review manual, vol. 3, part 3, 2001. p. 1-11.
3. Lang BH, Lo CY, Chan WF, Lam AK, Wan KY. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J Surg. 2006;30(5):752-8.
4. Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93:363-9.
5. Wolden-Kirk H, Gysemans C, Verstuyf A, Mathieu C. Extraskeletal effects of vitamin D. Endocrinol Metab Clin North Am. 2012;41(3):571-94.
6. lyer RL, Sirinvasin P, Joglekar M, Sikes RA, van Golen KL, Nohe A. Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines. Clin Exp Metastasis. 2012;29(8):971-9.
7. Pálmer HG, Sánchez-Carbayo M, Ordóñez- Morán P, Larriba MJ, Cordón-Cardó C, Muñoz A. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res. 2003;63(22):7799-806.
8. Nemazannikova N, Antonas K, Dass CR. Vitamin D: metabolism, molecular mechanisms, and mutations to malignancies. Mol Carcinog. 2013. doi: 10.1002/mc.21999.
9. Laney N, Meza J, Lyden E, Erickson J, Treude K, Goldner W. The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. Int J Endocrinol. 2010;2010:805716.
10. Stepien T, Krupinski R, Sopinski J, Kuzdak K, Komorowski J, Lawnicka H, Stepien H. Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer. Arch Med Res. 2010;41(3):190-4.
11. Pardanani A, Drake MT, Finke C, Lasho TL, Rozell SA, Jimma T, Tefferi A. Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: clinical correlates and prognostic studies. Am J Hematol. 2011;86(12):1013-6.
12. Sahin M, Taslipinar A, Kebapcilar L, Yilmaz H, Akgul OE, Beyhan Z, Ozgurtas T, Yaman H, Bolu E, Taslipinar MY, Delibasi T, Kutlu M. Low vitamin D3 levels in euthyroid hashimoto thyroiditis. Int Med J. 2012;19(4):317-320.
13. Bozkurt NC, Karbek B, Ucan B, Sahin M, Cakal E, Ozbek M, Delibasi T. The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocr Pract. 2013;21:1-14.
14. Chailurkit LO, Aekplakorn W, Ongphiphadhanakul B. High vitamin D status in younger individuals is associated with low circulating thyrotropin Thyroid. 2013;23(1):25-30. doi: 10.1089/thy.2012.0001.
15. Inoue M, Tsugane S. Insulin resistance and cancer: epidemiological evidence. Endocr Relat Cancer. 2012;19(5):F1-8.
16. Boyle P, Koechlin A, Pizot C, Boniol M, Robertson C, Mullie P, Bolli G, Rosenstock J, Autier P. Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis. Eur J Nutr. 2012. doi: 10.1007/s00394-012-0460-z.
17. Yasar HY, Ertuǧrul O, Ertuǧrul B, Ertuǧrul D, Sahin M. Insulin resistance in nodular thyroid disease. Endocr Res. 2011;36(4):167-74.
18. Rezzónico JN, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord. 2009;7(4):375-80.
19. Lippi G, Montagnana M, Targher G, Salvagno GL, Guidi GC. Prevalence of folic acid and vitamin B12 deficiencies in patients with thyroid disorders. Am J Med Sci. 2008;336(1):50-2.
20. Torréns JI, Burch HB. Serum thyroglobulin measurement. Utility in clinical practice. Endocrinol Metab Clin North Am. 2001;30(2):429-67.
21. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191-2.
22. Gokcel A, Ozsahin AK, Sezgin N, Karakose H, Ertorer ME, Akbaba M, Baklaci N, Sengul A, Guvener N. High prevalence of diabetes in Adana, a southern province of Turkey. Diabetes Care. 2003;26(11):3031-4.
23. Peehl DM, Krishnan AV, Feldman D. Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer. Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer. J Nutr. 2003;133(7 suppl):2461S-9S.
24. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, Jansen EH, Slimani N, Byrnes G, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Trichopoulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros MM, van Gils CH, Peeters PH, Brustad M, Lund E, Tormo MJ, Ardanaz E, Rodríguez L, Sánchez MJ, Dorronsoro M, Gonzalez CA, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Autier P, Hainaut P, Riboli E. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ. 2010;21(340):b5500.
25. Boi F, Minerba L, Lai ML, Marziani B, Figus B, Spanu F, Borghero A, Mariotti S Both thyroid autoimmunity and increased TSH are independent risk factors for malignancy in patients with thyroid nodules. J Endocrinol Invest. 2012 Aug 29. [Epub ahead of print].
26. Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid. 2010;20(2):135-46.